Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Self-reported attitudes and behaviors of general surgery residents about ethical academic practices in test taking.

Grignol VP, Gans A, Booth BA, Markert R, Termuhlen PM.

Surgery. 2010 Aug;148(2):178-80. doi: 10.1016/j.surg.2010.04.016. Epub 2010 Jun 9.

PMID:
20542528
2.

Fatty infiltration of the gastrocsoleus after tendo-achilles lengthening and gastrocnemius recession in a rabbit model.

Booth BA, Mistovich RJ, Janout M, Stills HF, Laughlin RT.

Foot Ankle Int. 2009 Aug;30(8):778-82. doi: 10.3113/FAI.2009.0778. Erratum in: Foot Ankle Int. 2009 Sep;30(9):vi.

PMID:
19735636
3.

Use of an acellular regenerative tissue matrix in combination with vacuum-assisted closure therapy for treatment of a diabetic foot wound.

Randall KL, Booth BA, Miller AJ, Russell CB, Laughlin RT.

J Foot Ankle Surg. 2008 Sep-Oct;47(5):430-3. doi: 10.1053/j.jfas.2008.04.012. Epub 2008 Jun 27.

PMID:
18725123
4.

Partner aggression among men and women in substance use disorder treatment: correlates of psychological and physical aggression and injury.

Chermack ST, Murray RL, Walton MA, Booth BA, Wryobeck J, Blow FC.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):35-44. doi: 10.1016/j.drugalcdep.2008.04.010. Epub 2008 Jun 13.

5.

Correlation of pain scores, analgesic use, and beck anxiety inventory scores during hospitalization in lower extremity amputees.

Trame CD, Greene E, Moddeman G, Booth BA, Konstantakos EK, Parada S, Siebuhr K, Laughlin RT.

Open Orthop J. 2008 Oct 24;2:145-50. doi: 10.2174/1874325000802010145.

6.

Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Booth BA, Vidal Denham L, Bouhanik S, Jacob JT, Hill JM.

Drugs Aging. 2007;24(7):581-602. Review.

PMID:
17658909
7.

Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis.

Langston W, Chidlow JH Jr, Booth BA, Barlow SC, Lefer DJ, Patel RP, Kevil CG.

Free Radic Biol Med. 2007 Mar 1;42(5):720-9. Epub 2006 Dec 16.

8.

Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.

Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D.

Oncogene. 2004 Mar 18;23(12):2206-15.

PMID:
14676833
9.

IGF-I and IGFBP-3 transport in the rat heart.

Boes M, Dake BL, Booth BA, Sandra A, Bateman M, Knudtson KL, Bar RS.

Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E237-9.

10.

Structure-function relationships of insulin-like growth factor binding protein 6 (IGFBP-6) and its chimeras.

Boes M, Dake BL, Booth BA, Sandra A, Bateman M, Knudtson K, Bar RS.

Growth Horm IGF Res. 2002 Apr;12(2):91-8.

PMID:
12175646
11.

IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis.

Booth BA, Boes M, Dake BL, Knudtson KL, Bar RS.

Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E52-8.

12.

Distribution of chimeric IGF binding protein (IGFBP)-3 and IGFBP-4 in the rat heart: importance of C-terminal basic region.

Knudtson KL, Boes M, Sandra A, Dake BL, Booth BA, Bar RS.

Endocrinology. 2001 Sep;142(9):3749-55.

PMID:
11517150
13.

Effect of IGFBP-derived peptides on incorporation of(35)SO(4)into proteoglycans.

Booth BA, Boes M, Dake BL, Caldwell EE, Weiler JM, Bar RS.

Growth Horm IGF Res. 2000 Aug;10(4):224-9.

PMID:
11032706
14.

Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells.

Boes M, Dake BL, Booth BA, Erondu NE, Oh Y, Hwa V, Rosenfeld R, Bar RS.

Endocrinology. 1999 Apr;140(4):1575-80.

PMID:
10098490
15.

Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3.

Booth BA, Boes M, Dake BL, Bar RS.

Am J Physiol. 1999 Mar;276(3):E450-4. doi: 10.1152/ajpendo.1999.276.3.E450.

PMID:
10070009
16.

Structure-function relationships in the heparin-binding C-terminal region of insulin-like growth factor binding protein-3.

Booth BA, Boes M, Dake BL, Linhardt RJ, Caldwell EE, Weiler JM, Bar RS.

Growth Regul. 1996 Dec;6(4):206-13.

PMID:
8971549
18.

IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments.

Booth BA, Boes M, Bar RS.

Am J Physiol. 1996 Sep;271(3 Pt 1):E465-70.

PMID:
8843739
19.

IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.

Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EE, Weiler J, et al.

Growth Regul. 1995 Mar;5(1):1-17.

PMID:
7538367
20.

Endothelial cells express insulin-like growth factor-binding proteins 2 to 6.

Moser DR, Lowe WL Jr, Dake BL, Booth BA, Boes M, Clemmons DR, Bar RS.

Mol Endocrinol. 1992 Nov;6(11):1805-14.

PMID:
1282670
21.
22.

Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I.

Bar RS, Boes M, Dake BL, Sandra A, Bayne M, Cascieri M, Booth BA.

Endocrinology. 1990 Dec;127(6):3243-5.

PMID:
2174349
23.

Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells.

Booth BA, Bar RS, Boes M, Dake BL, Bayne M, Cascieri M.

Endocrinology. 1990 Dec;127(6):2630-8.

PMID:
2174333
24.

Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart.

Bar RS, Clemmons DR, Boes M, Busby WH, Booth BA, Dake BL, Sandra A.

Endocrinology. 1990 Sep;127(3):1078-86.

PMID:
1696879
25.

Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart.

Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL, Booth BA.

Endocrinology. 1990 Jul;127(1):497-9.

PMID:
1694498
26.
27.

The effects of platelet-derived growth factor in cultured microvessel endothelial cells.

Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN.

Endocrinology. 1989 Apr;124(4):1841-8.

PMID:
2924726
28.

Insulin, insulin-like growth factors, and vascular endothelium.

Bar RS, Boes M, Dake BL, Booth BA, Henley SA, Sandra A.

Am J Med. 1988 Nov 28;85(5A):59-70. Review.

PMID:
2973748
29.

Comparative study of Vibrio cholerae non-O1 protease and soluble hemagglutinin with those of Vibrio cholerae O1.

Honda T, Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1987 Feb;55(2):451-4.

30.

Competitive enzyme-linked immunosorbent assay for cholera-related enterotoxins in Salmonella typhimurium.

Hariharan H, Booth BA, Brickman TJ, Katt WC, Boesman-Finkelstein M, Finkelstein RA.

J Clin Microbiol. 1986 Aug;24(2):298-300.

31.

Presence of hemagglutinin/protease and other potential virulence factors in O1 and non-O1 Vibrio cholerae.

Booth BA, Finkelstein RA.

J Infect Dis. 1986 Jul;154(1):183-6. No abstract available.

PMID:
3519790
32.

Vibrio cholerae hemagglutinin/protease nicks cholera enterotoxin.

Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1984 Sep;45(3):558-60.

33.

Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme.

Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1983 Nov;42(2):639-44.

34.

Steroid-induced dermal atrophy: effects of glucocorticosteroids on collagen metabolism in human skin fibroblast cultures.

Booth BA, Tan EM, Oikarinen A, Uitto J.

Int J Dermatol. 1982 Jul-Aug;21(6):333-7.

PMID:
7118346
35.

Purification and properties of poly(ADP-ribose) polymerase from lamb thymus.

Petzold SJ, Booth BA, Leimbach GA, Berger NA.

Biochemistry. 1981 Dec 8;20(25):7075-81.

PMID:
6274386
37.
38.
39.

Separation of progesterone-specific from CBG-like binding sites by chromatography on columns of spheroidal hydroxylapatite.

Booth BA, Dyer RD, Colás AE.

J Steroid Biochem. 1977 Nov;8(11):1179-82. No abstract available.

PMID:
926785
40.

Properties of two progesterone-binding proteins of the rat uterus.

Booth BA, Colás AE.

J Steroid Biochem. 1977 Nov;8(11):1171-7. No abstract available.

PMID:
562957
41.

A rapid technique to evaluate two high-affinity binding proteins in the same preparation.

Booth BA, Colás AE.

Anal Biochem. 1976 Nov;76(l):74-82. No abstract available.

PMID:
998979
42.

Potential antitumor agents. 14. 4-Substituted 2-formylpyridine thiosemicarbazones.

Agrawal KC, Booth BA, DeNuzzo S, Sartorelli.

J Med Chem. 1976 Oct;19(10):1209-14.

PMID:
994151
43.

Antineoplastic and biochemical properties of arylsulfonylhydrazones of 2-formylpyridine N-oxide.

Sartorelli AC, Agrawal KC, Booth BA, Pittman J, Bartholomew DG.

J Med Chem. 1976 Jun;19(6):830-3.

PMID:
181576
44.

Potential antitumor agents. 12. 2-Formyl-4-aminophenylpyridine thiosemicarbazones.

Agrawal KC, Booth BA, DeNuzzo SM, Sartorelli AC.

J Med Chem. 1975 Apr;18(4):368-71.

PMID:
1121002
45.

Binding interactions of progesterone and other C21 steroids with rat uterine cytosol.

Booth BA, Colás AE.

Gynecol Invest. 1975;6(5):272-84.

PMID:
1182025
46.

Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazones.

Mooney PD, Booth BA, Moore EC, Agrawal KC, Sartorelli AC.

J Med Chem. 1974 Nov;17(11):1145-50. No abstract available.

PMID:
4370274
47.

Comparative studies of the antineoplastic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone and its seleno-semicarbazone, guanylhydrazone and semicarbazone analogs.

Agrawal KC, Booth BA, Michaud RL, Moore EC, Sartorelli AC.

Biochem Pharmacol. 1974 Sep 1;23(17):2421-9. No abstract available.

PMID:
4429575
48.

Potential antitumor agents. 11. Inhibitors of alkaline phosphatase, an enzyme involved in the resistance of neoplastic cells to 6-thiopurines.

Agrawal KC, Lee MH, Booth BA, Moore EC, Sartorelli AC.

J Med Chem. 1974 Sep;17(9):934-8. No abstract available.

PMID:
4370275
49.

Potential antitumor agents. 9. 2-Formyl(m-amino)phenylpyridine thiosemicarbazones.

Agrawal KC, Lin AJ, Booth BA, Wheaton JR, Sartorelli AC.

J Med Chem. 1974 Jun;17(6):631-5. No abstract available.

PMID:
4857315
50.

Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.

Booth BA, Agrawal KC, Moore EC, Sartorelli AC.

Cancer Res. 1974 Jun;34(6):1308-14. No abstract available.

Supplemental Content

Loading ...
Support Center